Skip to content

Incidence of Middle Ear Barotrauma In Staged Versus Linear Chamber Compression During Hyperbaric Oxygen Therapy: A Double Blind, Randomized Clinical Trial

All New Patient Receiving Hyperbaric Oxygen Therapy Using Staged Or Linear Chamber Compression And The Incidence Of Middle Ear Barotrauma

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612000724875
Enrollment
100
Registered
2012-07-06
Start date
2012-09-13
Completion date
2014-12-08
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

All new patients presenting for hyperbaric oxygen therapy meeting the eligibility criteria will be randomized to either a Staged Compression Protocol (Trial regimen) or a Linear Compression Protocol (standard regimen) during their first hyperbaric chamber compression. Both protocols will achieve the treatment depth of 14 meters within 12-13 minutes. The Staged Protocol has a slightly faster compression rate (1.4 meters/min vs 1.1 meters/min) and has 2 holding stage with no pressure change to allow for patient to catch up with their ear equalization. The rate of compression and depth at the holding stages were choosen based on Boyle's Law calculation that middle ear volume will not change more than 30%. Photographs of the tympanic membranes will be taken pre and post the first session of hyperbaric oxygen therapy. The number of interrupted or aborted treatment and subjective pain score will also be recorded. The photographs will be assessed by a blinded experienced otolaryngologist for middle ear barotrauma grade. Primary outcome is incidence of middle ear barotrauma in staged versus linear protocols. Secondary outcomes are number of interrupted and aborted treatments and patient's comfort from the pain score. The hyperbaric doctors, hyperbaric nurses and the otolargyngologist assessor will all be blinded to protocol used. Only the chamber operator (who is not involved in the clinical management / assessment of the participants) will be aware of the protocol used. Sample size calculation require 50 participants per arm for a power of 80% to detect a difference. The department received on average 10 new patients per month and the research is anticipated to take one year.

Interventions

Staged Chamber Compression using the compression protocol as below: (atm = atmosphere; min = minutes) i)Compress from 1atm to 1.28atm @ 1.4meters/min for 2 mins, hold pressure for 1min ii)Compress from 1.28atm to 1.7atm @ 1.4meters/min for 3mins, hold pressure for 1min iii)Compress from1.7atm to 2.4atm @ 1.4meters/min for 5mins Total descent time = 12mins

Sponsors

Queensland Health
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

All adults aged 18 or above with indication for hyperbaric oxygen therapy

Exclusion criteria

Previous hyperbaric oxygen therapy, contraindications for hyperbaric oxygen therapy, patient with grommets, active otological conditions, tympanic membrane rupture, unconscious patient, prescribed hyperbaric treatment table other than 2.4ATA

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026